$0.00020
At close: Jul 28, 1:55 PM EDT
Comments
Loading...
Advanced Proteome Analyst Ratings and Price Targets | OTC:APTCF | Benzinga
Advanced Proteome Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Advanced Proteome Corp from these most-recent analyst ratings.
Analyst Ratings for Advanced Proteome
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Advanced Proteome (APTCF) stock?
There is no price target for Advanced Proteome
What is the most recent analyst rating for Advanced Proteome (APTCF)?
There is no analyst for Advanced Proteome
When was the last upgrade for Advanced Proteome (APTCF)?
There is no last upgrade for Advanced Proteome
When was the last downgrade for Advanced Proteome (APTCF)?
There is no last downgrade for Advanced Proteome.
When is the next analyst rating going to be posted or updated for Advanced Proteome (APTCF)?
There is no next analyst rating for Advanced Proteome.
Is the Analyst Rating Advanced Proteome (APTCF) correct?
There is no next analyst rating for Advanced Proteome.
Browse analyst ratings and price targets on all stocks.
